Oxyberberine alleviates lipopolysaccharide-induced intestinal barrier disruption and inflammation in human colonic Caco-2 cells in vitro - Li, Cailan; Wang, Jiahao; Yang, Hongmei; Luo, Shuang; Lu, Qiang (Frontiers in Pharmacology, 2025)